Biomedical, Clinical & Life Sciences

No applicants // Limit: 1 // Tickets Available: 1

T. Kalin ( Phoenix Children’s Research Institute -Translational Research) Subaward 

Hyundai Hope On Wheels® [“HHOW”] is a 501(c)(3) non-profit organization that joined the fight against childhood cancer in 1998. The organization funds life-saving research and creates awareness for childhood cancer. Since its inception, HHOW has donated more than $225 million to fund pediatric cancer research. 

In 2024, the following categories of research grants for pediatric cancer are available per this RFP: 

• Hope Scholar Grant: $400,000 (two-year award), please see pages 4-5 for details. 

• Young Investigator Grant: $250,000 (two-year award), please see page 6 for details. 

Eligibility to apply for a Hope Scholar or Young Investigator Grant is limited to Children’s Oncology Group (“COG”) member institutions in the U.S. Each eligible institution may submit up to one application per grant category. Applicants will be notified by March 15, 2024, about grant awardees. If selected, the first funding installment is planned for release on December 31, 2024. Approved research projects may begin upon receipt of the initial grant award disbursement. If selected, material conditions for the institution that receives a grant are to agree to all terms and conditions of the grant agreement, and to agree to host a Hyundai Hope On Wheels handprint ceremony at its location or virtually during August or September of 2024. 

No applicants // Limit: 1 // Tickets Available: 1

Hyundai Hope On Wheels® [“HHOW”] is a 501(c)(3) non-profit organization that joined the fight against childhood cancer in 1998. The organization funds life-saving research and creates awareness for childhood cancer. Since its inception, HHOW has donated more than $225 million to fund pediatric cancer research. 

In 2024, the following categories of research grants for pediatric cancer are available per this RFP: 

• Hope Scholar Grant: $400,000 (two-year award), please see pages 4-5 for details. 

• Young Investigator Grant: $250,000 (two-year award), please see page 6 for details. 

Eligibility to apply for a Hope Scholar or Young Investigator Grant is limited to Children’s Oncology Group (“COG”) member institutions in the U.S. Each eligible institution may submit up to one application per grant category. Applicants will be notified by March 15, 2024, about grant awardees. If selected, the first funding installment is planned for release on December 31, 2024. Approved research projects may begin upon receipt of the initial grant award disbursement. If selected, material conditions for the institution that receives a grant are to agree to all terms and conditions of the grant agreement, and to agree to host a Hyundai Hope On Wheels handprint ceremony at its location or virtually during August or September of 2024. 

 Limit: 1 // K. Lutrick (Research, Family & Community Medicine) & K. Ellingson (Epidemiology and Biostatistics)

Only one application per institution (normally identified by having a unique entity identifier [UEI] number) is allowed. 

The purpose of this Notice of Funding Opportunity (NOFO) is to establish: 1) a multi-site community-based cohort study that would allow close monitoring of the burden of acute respiratory illness in the community, contributions of various respiratory viruses to this burden, and the impact of vaccination and other interventions on risk of infection and/or severe outcomes, and 2) a case-ascertained household transmission study (or multi-site study) that would support ongoing assessment of transmission dynamics of respiratory viruses of interest and factors (i.e., demographic, clinical, or household-level factors) that may impact transmission.

While hospital-based platforms are key to assessing frequency and risk factors for severe disease, community-based platforms are essential for understanding age-specific incidences of infection, risk factors for infection, socioeconomic burden of infections (such as days of work/school lost), and the clinical spectrum of illness. They are important for characterizing the immune response to infection or reinfection and long-term outcomes, and they are key to understanding the impact of individual- and household-level mitigation factors (including but not limited to vaccination) on all of these measures. This type of network may be especially useful for detecting changes in any of these factors when a new virus or viral variant begins circulating.

Case-ascertained household transmission studies are well-positioned to quickly and efficiently enable us to understand transmission dynamics of respiratory viruses (or sublineages/types of existing viruses that undergo frequent mutation, such as SARS-CoV-2 and influenza) and assess potential mitigation factors. These studies can also be valuable for characterizing viral shedding dynamics and infectiousness. These studies were key during the COVID-19 pandemic to understanding if changes in hospitalization rates were due to changes in transmissibility/infection rates versus changes in severity of illness. They are also great resources for assessing how history of vaccination or prior history of infection effect transmission to close contacts.

This NOFO would build on the lessons learned during the COVID-19 pandemic and establish a consolidated network of community cohorts to monitor a range of respiratory viruses among community members who develop symptoms of acute respiratory illness. Incorporation of multi-pathogen testing will allow us to better understand the relative contribution of various viruses to the overall community burden of respiratory disease now in the post-pandemic setting, and how the clinical spectrum of these illnesses compare, in a setting in which multiple new preventive products are becoming available. This would also support the establishment of a case-ascertained transmission study (or multi-site study) that would be able to assess SARS-CoV-2, Respiratory Syncytial Virus (RSV), and other prioritized respiratory viruses on an ongoing basis.

The combination of these studies will generate much greater visibility on risk factors for infection and the effectiveness of various interventions in reducing infections and viral transmission, factors that are relevant to reducing overall morbidity and mortality related to respiratory viruses. Should a new variant or virus arrive, this platform would be well positioned to further expand testing to better understand potential concerns like proportion symptomatic, timing of transmission, likelihood of asymptomatic transmission and other related questions. Such questions may be key to developing public health guidance should additional mitigation measures become necessary.

Limit: 2 // Tickets Available: 1

S. Soto (Public Health)

To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions in the contiguous United States. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.

Applicants for the 2025 award must (i) not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2025; (ii) not have been or are not a principal investigator on an NIH R01 or equivalent national/international non-mentored award as of March 1, 2025; and (iii) dedicate at least 50% of their work effort to research. This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support but who design and conduct their own independent research projects.

The term of the Young Investigator Grant is two years, beginning on March 1, 2025. The grant provides salary support and project costs for a total of $125,000 (distributed over the two-year period as noted above.) Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs. 

Limit: 2 // Tickets Available: 1

G. Sutphin (Molecular and Cellular Biology)

The mission of Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved.

The research project must be directly related to the field of breast cancer. Areas of relevant research may include but are not limited to: diagnosis, etiology, immunology, genetics and epigenetics, therapies, prevention and clinical studies.

No applicants // Limit: 1 // Tickets Available: 1 

The University of Arizona Cancer Center (UACC) can nominate one application for this funding program.
For more information, please contact: UACC-PreAward.

UACC Limited Submission Information:

The University of Arizona Cancer Center (UACC) can nominate one applicant for the V Foundation Women Scientists Innovation Award for Cancer Research 2024.

Purpose of Award:

The UACC is seeking nominations for the Women Scientists Innovation Award for Cancer Research which supports women cancer researchers and is restricted to adult cancer research. 

Sustaining the careers of women in research and preventing the loss of women from academic careers focused on cancer is paramount to accomplishing the V Foundation’s mission. Women are underrepresented in many STEM fields and this disparity becomes more pronounced further along the career continuum. To make significant progress towards Victory Over Cancer®, we need all voices at the table. The V Foundation’s Women Scientists Innovation Award for Cancer Research helps promote inclusion for women in cancer research while supporting the most cutting-edge proposals.

Applicant Eligibility

Nominee must meet all of the following criteria by the nomination due date:

• Self-identify as a woman
• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• See additional criteria for Translational and V Scholar mechanisms listed in corresponding RFA and Supporting Documents.

If you have any question concerning eligibility and details regarding the opportunity, please contact the Grants Team at Grants@v.org in advance of applying.

For any other questions, please contact UACC-PreAward@arizona.edu.

Institutionally Coordinated // Limit: 1
Please contact RDS for more information. 

This award recognizes an outstanding assistant-level faculty member who demonstrates leadership potential in addressing inequity in medical education and health care; demonstrates efforts in addressing educational, societal, and health care needs of racial and ethnic minorities in the United States; and is committed to a career in academic medicine.

The recipient receives a $25,000 grant to support a project performed in the United States to support racial and ethnic minorities. Recipients are required to accept the award at Learn Serve Lead 2024: The AAMC Annual Meeting in Atlanta, GA.

A medical school may nominate one current faculty member per year for this award. A candidate must:

• Be a U.S. citizen or permanent resident.
• Hold the rank of full-time assistant professor in a LCME-accredited U.S. medical school department.
• Have held the assistant professor position appointment beginning no earlier than July 1, 2021.
• Have received only one appointment as assistant professor.
• Hold a MD, PhD, or have earned another doctoral degree.

No Applicants // Limit: 1 // Tickets Available: 1 

Only one application per institution (normally identified by having a unique UEI number) is allowed.

This Notice of Funding Opportunity (NOFO) supports research to implement and evaluate strategies aligned with CDC’s What Works in Schools (WWIS) approach for successful implementation in local education agencies and schools serving rural or American Indian and/or Alaska Native (AI/AN) adolescents to address students’ health behaviors, experiences, and outcomes, particularly those related to sexual and reproductive health and mental and behavioral health, as well as suicidality, substance use, and experiences of violence. The purpose of the research is to build the evidence base for innovative, school-based or school-linked strategies that promote the health of youth across multiple health domains while also supporting translation and dissemination of the research findings. Strategies may include programs, policies, or practices that seek to improve sexual and reproductive health as well as improve mental and behavioral health in a manner that also addresses health equity among youth in local education agencies and schools serving rural or AI/AN adolescents. Additionally, strategies may also seek to reduce suicidality, substance use and experiences of violence among school-aged adolescents.

The estimated total funding (direct and indirect) for the first year (12-month budget period) will be $1,000,000.00 with individual awards of $500,000.00 each for two awards. The estimated total funding (direct and indirect) for the entire project period will be $5,000,000.00. The project period is anticipated to run from 09/29/2024 to 09/28/2029.

Limit: 1 // PI: N. Halvax ( Family & Community Medicine)

AHCCCS is investing funds from the American Rescue Plan (ARP) into an award program to strengthen Home and Community Based Services (HCBS) in the state. You can find more information on the ARP and Arizona’s spending plans on the AHCCCS ARP Allocations web page.

The ARP Program Awards are intended to enhance the health, safety, and member experience for individuals who receive HCBS. AHCCCS members who can directly benefit include Arizona Long Term Care System (ALTCS) and non-ALTCS members like:

• Individuals who are elderly,
• Individuals with disabilities,
• Individuals living with a Serious Mental Illness (SMI) designation, and
• Children with behavioral health needs.

Eligible HCBS providers can request between $10,000 and $1,000,000 for programmatic or infrastructure projects

 Limit: 1 // H. Ding (Translational Pharmacogenomics)

One nomination will be invited from each of the participating institutions.

The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level. The current grant level is $300,000; $75,000 per year for a four-year period.

Candidates must hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Candidates must meet all of the following eligibility requirements:

• Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
• As of Sept. 7, 2024, run an independent lab and hold a full-time appointment at the rank of assistant professor.
• Must not have been appointed as an assistant professor at any institution prior to June 12, 2020, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
  • Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
• May apply to the program a maximum of two times. 
• If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
• May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.